Acquisition by Dalessandro Danilo of 8291 shares of Clearpoint Neuro subject to Rule 16b-3

CLPT Stock  USD 15.44  0.31  1.97%   
Slightly above 63% of Clearpoint Neuro's investor base is looking to short. The analysis of overall sentiment of trading Clearpoint Neuro stock suggests that many investors are alarmed at this time. Clearpoint Neuro's investing sentiment can be driven by a variety of factors including economic data, Clearpoint Neuro's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Clearpoint Neuro Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at massdevice.com
news
  
Clearpoint insider trading alert for acquisition of restricted stock units by D'alessandro Danilo, Officer: Chief Financial Officer, on 11th of March 2024. This event was filed by Clearpoint Neuro with SEC on 2024-03-11. Statement of changes in beneficial ownership - SEC Form 4

Clearpoint Neuro Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Clearpoint Neuro can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Clearpoint Neuro Fundamental Analysis

We analyze Clearpoint Neuro's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearpoint Neuro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearpoint Neuro based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Flow From Operations

Cash Flow From Operations Comparative Analysis

Clearpoint Neuro is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Clearpoint Neuro Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clearpoint Neuro stock to make a market-neutral strategy. Peer analysis of Clearpoint Neuro could also be used in its relative valuation, which is a method of valuing Clearpoint Neuro by comparing valuation metrics with similar companies.

Peers

Clearpoint Neuro Related Equities

NARIInari Medical   22.23   
0%
100.0%
INSPInspire Medical   5.25   
0%
23.0%
NPCENeuropace   4.11   
0%
18.0%
RCELAvita Medical   3.00   
0%
13.0%
KIDSOrthopediatrics Corp   1.60   
0%
7.0%
TELATela Bio   0.35   
1.0%
0%
APYXApyx Medical   0.58   
2.0%
0%
LIVNLivaNova PLC   1.09   
4.0%
0%
LUNGPulmonx Corp   1.20   
5.0%
0%
INGNInogen   1.47   
6.0%
0%
TMCITreace Medical   1.80   
8.0%
0%
SRDXSurModics   1.84   
8.0%
0%
SGHTSight Sciences   2.65   
11.0%
0%
CTSOCytosorbents Crp   2.88   
12.0%
0%
ELMDElectromed   2.98   
13.0%
0%
OMOutset Medical   13.39   
60.0%
0%

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.